Yamakoshi, Takehiro
Rolfe, Peter
Yamakoshi, Ken-ichi
Funding for this research was provided by:
Japan Society for the Promotion of Science (16H02900, 24680063)
Japan Atherosclerosis Research Foundation
Article History
Received: 31 May 2022
Accepted: 7 October 2022
First Online: 14 November 2022
Competing interests
: Prof. Peter Rolfe currently serves as the Director of Science and Technology for Oxford BioHorizons Ltd., a consultancy company, outside of the submitted work. The remaining authors declare no potential conflicts of interest.